Literature DB >> 17703961

Asymptomatic shedding of herpes simplex virus (HSV) in the oral cavity.

Craig S Miller1, Robert J Danaher.   

Abstract

OBJECTIVE: The aim of this study was to investigate the rate of herpes simplex virus (HSV) shedding from the oral cavity, because recent studies suggest that shedding is more frequent than originally reported. Factors that could influence the rate and duration of shedding from the oral cavity were examined.
METHODS: Existing epidemiologic data from 22 reports of HSV shedding from more than 3,500 individuals were analyzed with regard to demographics, frequency of sampling, and methodologic assays.
RESULTS: HSV-1 was more likely to be detected than HSV-2 in the oral cavity of asymptomatic persons (7.5 odds ratio, 95% confidence interval 4.4-12.8; P < .0001). The rate of shedding was highly variable among individuals, ranging from none to 92% of days tested, and occurred in seropositive and seronegative individuals. In cell culture studies, the rate of detection on a single day was 6.3%. Polymerase chain reaction studies provided a different picture. HSV-1 DNA was present in 97 of 180 patients (53.9%) at multiple visits, with a rate of daily detection of 33.3%. The mean duration of shedding was between 1 and 3 days, but more than 3 days in about 10% of patients.
CONCLUSIONS: At least 70% of the population shed HSV-1 asymptomatically at least once a month, and many individuals appear to shed HSV-1 more than 6 times per month. Shedding of HSV-1 is present at many intraoral sites, for brief periods, at copy numbers sufficient to be transmitted, and even in seronegative individuals. The dental implications of these findings are discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17703961     DOI: 10.1016/j.tripleo.2007.06.011

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod        ISSN: 1079-2104


  31 in total

1.  Burning mouth syndrome due to herpes simplex virus type 1.

Authors:  Maria A Nagel; Alexander Choe; Igor Traktinskiy; Don Gilden
Journal:  BMJ Case Rep       Date:  2015-04-01

2.  Reactivation of type 1 herpes simplex virus and varicella zoster virus in an immunosuppressed patient with acute peripheral facial weakness.

Authors:  Jean Tsai; Randall J Cohrs; Maria A Nagel; Ravi Mahalingam; D Scott Schmid; Alexander Choe; Don Gilden
Journal:  J Neurol Sci       Date:  2011-09-15       Impact factor: 3.181

3.  HSV-1 clinical isolates with unique in vivo and in vitro phenotypes and insight into genomic differences.

Authors:  Robert J Danaher; Derrick E Fouts; Agnes P Chan; Yongwook Choi; Jessica DePew; Jamison M McCorrison; Karen E Nelson; Chunmei Wang; Craig S Miller
Journal:  J Neurovirol       Date:  2016-10-13       Impact factor: 2.643

Review 4.  Latent versus productive infection: the alpha herpesvirus switch.

Authors:  Orkide O Koyuncu; Margaret A MacGibeny; Lynn W Enquist
Journal:  Future Virol       Date:  2018-05-22       Impact factor: 1.831

Review 5.  Ocular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?

Authors:  Lena J Al-Dujaili; Patrick P Clerkin; Christian Clement; Harris E McFerrin; Partha S Bhattacharjee; Emily D Varnell; Herbert E Kaufman; James M Hill
Journal:  Future Microbiol       Date:  2011-08       Impact factor: 3.165

Review 6.  Herpes Simplex Virus Latency Is Noisier the Closer We Look.

Authors:  Navneet Singh; David C Tscharke
Journal:  J Virol       Date:  2020-01-31       Impact factor: 5.103

7.  Effect of high versus low oral doses of valacyclovir on herpes simplex virus-1 DNA shedding into tears of latently infected rabbits.

Authors:  Manish Kumar; Herbert E Kaufman; Christian Clement; Partha S Bhattacharjee; Tashfin S Huq; Emily D Varnell; Hilary W Thompson; James M Hill
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-14       Impact factor: 4.799

8.  Acute primary herpetic gingivostomatitis.

Authors:  Ravi Prakash Sasankoti Mohan; Sankalp Verma; Udita Singh; Neha Agarwal
Journal:  BMJ Case Rep       Date:  2013-07-08

9.  A double-blind placebo-controlled study to evaluate valacyclovir alone and with aspirin for asymptomatic HSV-1 DNA shedding in human tears and saliva.

Authors:  Manish Kumar; James M Hill; Christian Clement; Emily D Varnell; Hilary W Thompson; Herbert E Kaufman
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-15       Impact factor: 4.799

10.  Herpes simplex virus reactivation and dental procedures.

Authors:  L El Hayderi; P Delvenne; E Rompen; J M Senterre; A F Nikkels
Journal:  Clin Oral Investig       Date:  2013-04-21       Impact factor: 3.573

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.